Editorial
Published on 18 Feb 2026
Editorial: Salt-sensitive hypertension: mechanisms, therapeutics, and beyond
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1790409
- 197 views
Type at least 3 characters
1,846 articles
articles
Review
Accepted on 11 Feb 2026
The Role of Immune Regulation in Peripheral Nerve Regeneration: Functions of Inflammatory Cells and Cytokines
in Inflammation Pharmacology
Frontiers in Pharmacology
- 163 views
Clinical Trial
Accepted on 09 Feb 2026
Low-dose naltrexone as an adjunctive treatment for major depressive disorder: Findings from a randomized, double-blind, placebo-controlled hybrid parallel-arm study
in Inflammation Pharmacology
Frontiers in Pharmacology
- 179 views
Original Research
Published on 09 Feb 2026
1-Nitropyrene induces acute lung injury via SYVN1/Caspase-11-mediated apoptosis and pyroptosis in pulmonary epithelial cells
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1723593
- 438 views
Original Research
Published on 09 Feb 2026
Characterization and anti-inflammatory studies of supramolecular assemblies of chlorogenic acids with metal ions
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1726226
- 364 views
Original Research
Published on 06 Feb 2026
7-Dehydrocholesterol attenuates osteoarthritis by synergistically inhibiting oxidative stress, inflammation, and ferroptosis in macrophages
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1760112
- 547 views
Original Research
Accepted on 05 Feb 2026
Thymoquinone Combined with Conventional Antibiotics Against Pandrug-Resistant Staphylococcus aureus: A Pharmacodynamic and Molecular Simulation Strategy to Overcome Bioavailability Limitations
in Inflammation Pharmacology
Frontiers in Pharmacology
- 189 views
Original Research
Accepted on 03 Feb 2026
A thermosensitive hydrogel encapsulating 2-DG alleviates periodontitis by inhibiting glycolysis and effector response of Th17 cells
in Inflammation Pharmacology
Frontiers in Pharmacology
- 231 views
Original Research
Published on 02 Feb 2026
Hydroxysafflor yellow A attenuates sepsis-induced intestinal barrier dysfunction by modulating Bcl-2/SOD2-mediated mitochondrial apoptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1728183
- 512 views
Review
Accepted on 30 Jan 2026
Upadacitinib in Rheumatoid Arthritis: Progress and Challenges
in Inflammation Pharmacology
Frontiers in Pharmacology
- 234 views
Original Research
Published on 30 Jan 2026
Quercetin regulates autophagy and attenuates airway inflammation in a murine model of asthma: association with PI3K/Akt/mTOR signaling pathway modulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1755094
- 667 views
Review
Accepted on 29 Jan 2026
Chronic Inflammation as a Driving Factor for Sarcopenia: An Update on Pathophysiology and Future Therapeutic Targets
in Inflammation Pharmacology
Frontiers in Pharmacology
- 294 views
Systematic Review
Published on 28 Jan 2026
The efficacy of artesunate in animal models of sepsis: a systematic review and meta-analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1748083
- 651 views
Review
Accepted on 26 Jan 2026
Early Biomarkers for Predicting Sepsis-Induced Shock: Insights from Inflammatory Pathways and Immune Response
in Inflammation Pharmacology
Frontiers in Pharmacology
- 158 views
Original Research
Published on 26 Jan 2026
Multi-omics integration identifies ganoderic acid A as a TNFα inhibitor for treating sepsis-related liver injury
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1754172
- 524 views
Review
Accepted on 22 Jan 2026
The spatiotemporal dynamic evolution of post-stroke neuroinflammation: Energy metabolism mechanisms of acute response and chronic progression
in Inflammation Pharmacology
Frontiers in Pharmacology
- 139 views
Original Research
Published on 22 Jan 2026
Multi-omics integration and machine learning-driven construction of an immunogenic cell death prognostic model for colon cancer and functional validation of FCGR2A
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1746907
- 694 views
Correction
Published on 22 Jan 2026
Correction: Omega 3 fatty acid docosahexaenoic acid (DHA) mitigates inflammatory responses in experimental sepsis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2026.1782326
- 451 views
Systematic Review
Published on 20 Jan 2026
Knowledge domain and evolutionary trends of P2Y receptors in cardiovascular diseases: a bibliometric and altmetric analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1731397
- 954 views
Review
Published on 15 Jan 2026
Glutathione and neurodegenerative diseases: immunopharmacological implications
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1737199
- 1,052 views
Review
Published on 12 Jan 2026
Cycloastragenol in inflammation-related diseases: mechanisms, pharmacokinetics, and translational prospects
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1732996
- 1,043 views
Original Research
Published on 12 Jan 2026
Partially hydrolyzed formula with high sn-2 palmitic acid on eosinophils and outcomes in preterm infants: PRIOR secondary analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1724281
- 689 views
Review
Published on 07 Jan 2026
Advances in pulmonary neuroendocrine cells and their cellular interactions in asthma pathogenesis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1725531
- 832 views
Review
Published on 07 Jan 2026
κ-opioid receptor: from analgesic target to neuroimmune hub
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1744231
- 1,139 views